Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“PLEASE SHOUT MORE!” exclaims the amused peanut gallery..
AGREED BROTHER. OVER 31% INSTITUTION OWNED!!!!!
The corrupted pieces of total trash needs their criminal butts burned over $0.25 and then over $0.30 this week.
,,,,,,,LOOKS LIKE WE GOT HELLA TRAPPED…SHORTS HERE
MIGHT HAVE TO RAISE MY .38 target to .52 HEHE
Corrupt MM manipulation is the only reason why it's not over $0.25 at this point, the corrupted manipulators need to be squeezed.
That was at 3:25 a.m. on March 30th when it shot up to .415. I have been out of this ticker ever since that day.
Great sure you did not swap the 1 and 4
Well this popped up to .415 in premarket. Let's see what it does during regular hours today.
still 26, what to expect on the 30th ? Anyone with a fundamental outlook 3months or 12months ? What a desaster with this stock ...
How about that advertising new hire ? Guess I missed the super bowl commercial
Because today we are sub .25
How about sub .25
Ski slope chart...with no moguls.
Which Tuesday…. Next year ?
Maybe check back tuesday
Maybe it'll fall to $0.46 or $0.47.....????
So how do folks feel about AGRX?
Seems to me that dilution above and beyond the ATM is a given. Need a big uptick in scripts to avoid the additional dilution.
Am I too pessimistic?
$AGRX check out their products: https://agiletherapeutics.com/our-product/#top
#BREAKINGNEWS! Agile Therapeutics $AGRX Q2 2021 Earnings Call Transcript https://finance.yahoo.com/m/b12c07b2-70f3-35ca-9a08-5c7012c0b0cb/agile-therapeutics-agrx-q2.html
$AGRX Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
$AGRX Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 https://finance.yahoo.com/news/agile-therapeutics-report-second-quarter-120500287.html
Back to support on the chart.
more insider purchases at $2.01
Principal Accounting Officer
HDG. re Tenapanor ( Ibsreia ) ...Its not being used by dialysis patients in either the hospital or the dialysis units my wife rounds on .
Its not unusual for it to take up over a year for a new CKD / dialysis drug to gain acceptance in the clinic . They always want long term data on large numbers and preferably wait till head of Dept attends a conference and then orders use on return .
Theres also the cost issue
HDG re Tenapanor. Dialysis patients are in dialysis chairs for up to 4 hrs , 3,times a week
The “ loose stool “‘... more frequent bowel movements associated with T , makes transition to this drug difficult for many .
Quick take ... believe ( but will chk later ) staff will not stop treatment ( dialysis machine ) if patient needed the bathroom
Kiwi
K-
Check this one (AGRX).
What is your wife's view / opinion?
Tenapanor: First-in-class product candidate for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. (Three successful statistically significant Phase 3 studies).
Best,
G
Check out the short selling.
https://nakedshortreport.com/company/AGRX
If true, we could see some fireworks
tons of volume big blocks
3x800,000 at $3.00
AGRX Agile Therapeu... HC Wainwright & Co. Maintains Buy 6.00 7.00
Wait for the first sale for the day traders to pump this sucker up!
5-8% of the 4.1B market equates to ~205-330M annual sales. If we achieve the lower end 205M annual, trading at 3x sales would put us at ~$7 and 5x sales would put our valuation at around 1B or ~$12. I would assume in the long run that the former valuation is Agile’s worst case scenario. The realistic best case scenario would be trading at 5x 330M annual sales, which would put us at ~$19.5.
CFO insider purchase
9/28/2020 P 9000 A $2.85
Followers
|
56
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1203
|
Created
|
06/23/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |